Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Theravance Biopharma (TBPH) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Theravance Biopharma's Amortizatization of Intangibles fell 1124.89% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1728.96%. This contributed to the annual value of $4.4 million for FY2024, which is 631.02% up from last year.
  • Per Theravance Biopharma's latest filing, its Amortizatization of Intangibles stood at $1.0 million for Q3 2025, which was down 1124.89% from $940000.0 recorded in Q2 2025.
  • Over the past 5 years, Theravance Biopharma's Amortizatization of Intangibles peaked at $1.7 million during Q4 2022, and registered a low of $341000.0 during Q1 2022.
  • Its 5-year average for Amortizatization of Intangibles is $1.0 million, with a median of $1.0 million in 2021.
  • Per our database at Business Quant, Theravance Biopharma's Amortizatization of Intangibles crashed by 5410.5% in 2022 and then skyrocketed by 20234.6% in 2023.
  • Quarter analysis of 5 years shows Theravance Biopharma's Amortizatization of Intangibles stood at $1.0 million in 2021, then soared by 65.86% to $1.7 million in 2022, then decreased by 16.25% to $1.4 million in 2023, then fell by 26.26% to $1.1 million in 2024, then dropped by 4.84% to $1.0 million in 2025.
  • Its Amortizatization of Intangibles stands at $1.0 million for Q3 2025, versus $940000.0 for Q2 2025 and $966000.0 for Q1 2025.